海航控股(600221.SH):海島臨空擬出資25億元增資海航技術
格隆匯5月26日丨海航控股(600221.SH)公佈,海南海島臨空產業集團有限公司(以下簡稱“海島臨空”)擬出資人民幣25億元增資海南航空控股股份有限公司(以下簡稱“海航控股”或“公司”)的全資子公司海航航空技術有限公司(以下簡稱“海航技術”)。
本次交易構成關聯交易,但不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
本次交易有利於海航技術充實註冊資本金、降低資產負債率,促進海航技術業務升級及市場拓展。本次增資後,海航技術仍為公司控股子公司,公司可享受海航技術優質發展的成果。本次交易預計將對公司未來的發展產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.